Bovine Herpes Virus Type 1 Vaccine

Bioveta BioBos IBR Marker vaccine is indicated for the active immunization of cattle against conjunctivitis and vulvovaginitis.

Reduce clinical symptoms: It lessens the intensity and duration of symptoms caused by infection with Bovine Herpesvirus type 1 (BHV-1), the causative agent of Infectious Bovine Rhinotracheitis (IBR).
Decrease viral shedding: It significantly reduces the excretion of the field virus from infected animals, helping to limit environmental spread.
Enable DIVA Differentiation: As a “marker” vaccine (gE-negative), it allows veterinarians to differentiate infected from vaccinated animals (DIVA principle) using specific ELISA diagnostic tests.

Method: Intramuscular (IM) injection in the neck.
Dosage: 2 mL per animal.
Age: Initial vaccination at 3 months or older.
Booster: A second dose is recommended 3 weeks after the first, with subsequent boosters every 6 months.
Preparation: The vaccine should be shaken well before use, and allow to reach 15°C – 25°C.
Note: Bioveta.eu indicates that a 10-fold overdose does not cause adverse effects.